Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LGT-371 crossover study in obstructive sleep apnoea
ACTRN12618001579280Phase 2Completed
- Sponsor
- Monash University
- Start
- Jun 2022
- Countries
- 1
01
Overview
Phase 2 trial of LGT-371 in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Monash University. Primary endpoints: Apnoea/hypopnoea index and Loop gain. Started Jun 2022; status: completed.
02
Drugs
LGT-371
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12618001579280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001579280.